Non-alcoholic fatty liver disease (NAFLD) has rapidly become the most common liver
disease globally and is currently estimated to affect 38% of the global population. Only a …

Nonalcoholic fatty liver disease (NAFLD) has emerged as a leading cause of liver-related
morbidity and mortality worldwide, afflicting approximately a billion individuals. NAFLD is a …

Abstract Non-Alcoholic Fatty Liver Disease (NAFLD) refers to the accumulation of lipid laden
vacuoles in hepatocytes, occurring in the context of visceral adiposity, insulin resistance and …

Background & Aims Metabolic dysfunction-associated steatotic liver disease (MASLD;
formerly NAFLD) is the fastest growing cause of hepatocellular carcinoma (HCC) worldwide …

Non-alcoholic fatty liver disease (NAFLD) is the most prevalent chronic liver disease, and is
related to fatal and non-fatal liver, metabolic, and cardiovascular complications. Its non …

Non-alcoholic fatty liver disease (NAFLD) represents a major public health concern and is
associated with a substantial global burden of liver-related and cardiovascular-related …

Metabolic dysfunction-associated steatotic liver disease (MASLD), formerly known as
nonalcoholic fatty liver disease (NAFLD), is a prevalent chronic liver disease worldwide …

Metabolic dysfunction-associated steatotic liver disease (MASLD), formerly defined as non-
alcoholic fatty liver disease (NAFLD), is a disorder marked by the excessive deposition of …

Nonalcoholic fatty liver disease (NAFLD) is a common liver disease with a wide spectrum of
liver conditions ranging from hepatic steatosis to nonalcoholic steatohepatitis (NASH) …

Nonalcoholic fatty liver disease (NAFLD), a chronic condition associated with metabolic
dysfunction and obesity, has reached epidemic proportions worldwide. Although early …